Axonics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AXNX research report →
About the company
Axonics, Inc. is a medical device firm that focuses on developing and bringing to market sacral neuromodulation (SNM) solutions. These advanced SNM systems are designed to address a range of medical conditions, such as overactive bladder (including urinary urge incontinence and frequent urges to urinate), alongside fecal incontinence and non-obstructive urinary retention.
- CEO
- Raymond W. Cohen
- IPO
- 2018
- Employees
- 797
- HQ
- Irvine, CA, US
Price Chart
- Market Cap
- $3.63B
- P/E
- -572.24
- P/S
- 9.90
- P/B
- 5.46
- EV/EBITDA
- 456.66
- Div Yield
- 0.00%
- Gross Margin
- 74.94%
- Op Margin
- -7.11%
- Net Margin
- -1.66%
- ROE
- -1.01%
- ROIC
- -2.68%
- Revenue
- $366.38M · 33.86%
- Net Income
- $-6,088,000 · 89.80%
- EPS
- $-0.12 · 90.63%
- Op Income
- $-26,057,000
- FCF YoY
- -675.00%
- 52W High
- $70.98
- 52W Low
- $70.98
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.83
- Avg Volume
- 0
Get TickerSpark's AI analysis on AXNX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 15, 24 | Kiernan Jane E | sell | 19,861 |
| Nov 15, 24 | Woock John | sell | 13,125 |
| Nov 15, 24 | Woock John | sell | 3,581 |
| Nov 15, 24 | Woock John | sell | 15,555 |
| Nov 15, 24 | Woock John | sell | 77,403 |
| Nov 15, 24 | snyderman nancy lynn MD | sell | 14,944 |
| Nov 15, 24 | snyderman nancy lynn MD | sell | 4,167 |
| Nov 15, 24 | snyderman nancy lynn MD | sell | 10,000 |
| Nov 15, 24 | Sama Rinda | sell | 608 |
| Nov 15, 24 | Sama Rinda | sell | 9,962 |
Our AXNX coverage
Recent articles, reports, and earnings notes.
No research on AXNX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AXNX report →Similar companies
Peers in the same neighborhood.